Sido Muncul

Sido Muncul produces modern herbal medicines, including Tolak Angin, Kuku Bima Ener-G!, and over 300 other products, and holds the largest market share in Indonesia.

Sido Muncul produces modern herbal medicines, including Tolak Angin, Kuku Bima Ener-G!, and over 300 other products, and holds the largest market share in Indonesia.

PT Sido Muncul Tbk, a producer of modern herbal medicines and traditional remedies since 1975, reports a net profit of **IDR 619 billion** for the first nine months of 2026. The company adjusts its sales mix to achieve this financial performance. Sido Muncul operates in Indonesia’s health and wellness sector, leveraging its long-standing heritage in herbal formulations.

Oct 2026idnfinancials.comNews article

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) announces an IDR 10 per-share interim dividend for its 2026 financial year, totaling IDR 300 billion. This marks the lowest interim dividend payout since 2020. The company allocates funds to shareholders while managing financial constraints.

Oct 2026idnfinancials.comNews article

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) CEO Irwan Hidayat advocates for Indonesia to develop self-sufficiency in plant-based traditional medicines. The push aligns with broader efforts to reduce reliance on imported herbal remedies and strengthen domestic pharmaceutical capabilities. SIDO specializes in jamu, Indonesia’s traditional herbal medicine sector.

Apr 2026idnfinancials.comNews article

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) shareholders approve a final dividend of **IDR 441.5 billion (IDR 15 per share)** from the **2025 financial year profits**. The company also appoints **Irwan Hidayat** as its new **President Director**. The dividend reflects earnings distribution to shareholders following the fiscal year’s performance.

Apr 2026idnfinancials.comNews article